Bromocriptine

Overview

Bromocriptine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL493).

API suppliers (2)

Suppliers of Bromocriptine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Lek Pharmaceuticals D.D.Slovenia1 active DMF
• Gedeon RichterHungary

Patent & exclusivity (US)

Per the FDA Orange Book (7 approved US products), the latest listed US patent on Bromocriptine expires 29 Apr 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Canonical SMILES

CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O

InChIKey

OZVBMTJYIDMWIL-AYFBDAFISA-N